Institutional Ownership
Stoke Therapeutics Inc
CUSIP 86150R107COMSTOKQ1 2026
13D / 13G Filings
57
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
47.5%
Max % of class reported
Institutional Holders
191
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
57 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Baker Bros. Advisors LP | 13G/A | 5.8% | 3.34M | SEC |
| 2 | Feb 5, 2026 | Fmr LLC | 13G/A | 9.8% | 5.60M | SEC |
| 3 | Nov 14, 2025 | Cowen Financial Products LLC | 13G/A | — | — | SEC |
| 4 | Nov 14, 2025 | The Toronto-Dominion Bank | 13G | 5.8% | 3.17M | SEC |
| 5 | Nov 5, 2025 | Fmr LLC | 13G/A | 12.5% | 6.87M | SEC |
| 6 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 6.8% | 3.73M | SEC |
| 7 | Aug 26, 2025 | Blue Horizon Enterprise Ltd | 13D/A | 4.1% | — | SEC |
| 8 | Aug 14, 2025 | Redmile Group, LLC | 13G/A | 8.0% | 4.38M | SEC |
| 9 | Aug 6, 2025 | Fmr LLC | 13G/A | 13.6% | 7.41M | SEC |
| 10 | Jul 29, 2025 | Cowen Financial Products LLC | 13G/A | 5.8% | 3.17M | SEC |
47 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Stoke Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rtw Investments, LP | 5.62M | $183.10M |
| 2 | Blackrock, Inc. | 5.39M | $175.36M |
| 3 | Fmr LLC | 5.38M | $175.29M |
| 4 | Lynx1 Capital Management LP | 4.76M | $155.11M |
| 5 | Redmile Group, LLC | 4.16M | $135.58M |
| 6 | Morgan Stanley | 3.42M | $111.46M |
| 7 | Baker Bros. Advisors LP | 3.34M | $108.64M |
| 8 | Toronto Dominion Bank | 3.17M | $103.32M |
| 9 | Wellington Management Group LLP | 3.10M | $100.80M |
| 10 | Bvf Inc/Il | 2.55M | $82.95M |